Intellia Therapeutics (NTLA)
(Delayed Data from NSDQ)
$20.02 USD
-1.15 (-5.43%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $20.04 +0.02 (0.10%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-1.35 | -3.02% |
Earnings Summary
For their last quarter, Intellia Therapeutics (NTLA) reported earnings of -$1.46 per share, beating the Zacks Consensus Estimate of $-1.47 per share. This reflects a positive earnings surprise of 0.68%. Look out for NTLA's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$1.35 per share, reflecting a year-over-year decrease of 15.38%.
Earnings History
Price & Consensus
Zacks News for NTLA
Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q1 Earnings Expected to Decline
NTLA: What are Zacks experts saying now?
Zacks Private Portfolio Services